Humans are highly susceptible to infection with respiratory viruses including respiratory
syncytial virus (RSV), influenza virus, human metapneumovirus, rhinovirus, coronavirus, and …

Survival rates for pediatric cancer have steadily improved over time but it remains a
significant cause of morbidity and mortality among children. Infections are a major …

T-cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
been described in recovered patients, and may be important for immunity following infection …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Despite advances, few therapeutics have shown efficacy in severe coronavirus disease
2019 (COVID-19). In a different context, virus-specific T cells have proven safe and effective …

Viral infections are common and are potentially life-threatening in patients with moderate to
severe primary immunodeficiency disorders. Because T-cell immunity contributes to the …

Although the importance of virus-specific cytotoxic T lymphocytes (CTL) in virus clearance is
evident in COVID-19, the characteristics of virus-specific CTLs related to disease severity …

Negative-stranded RNA viruses (NSVs) are important human pathogens, including
emerging and reemerging viruses that cause respiratory, hemorrhagic and other severe …

Human metapneumovirus (hMPV) is a respiratory virus, first reported the year 2001. Since
then, it has been described as one of the main etiological agents that causes acute lower …

Adoptive immunotherapy with virus-specific cytotoxic T cells (VSTs) has evolved over the
last three decades as a strategy to rapidly restore virus-specific immunity to prevent or treat …